INVENTIVA SA INVENTIVA ORD SHS - stock earnings
0RNK.L Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -27.6 million EUR | 3.3 million EUR |
| 2023Q1 | -27.6 million EUR | 3.3 million EUR |
| 2022Q4 | -12.4 million EUR | 7.7 million EUR |
| 2022Q3 | -12.4 million EUR | 7.7 million EUR |
| 2021Q2 | -23.1 million EUR | 139000 EUR |
| 2020Q4 | -18.0 million EUR | 211000 EUR |
0RNK.L Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -54.3 million EUR | 18.8 million EUR |
| 2021 | -49.6 million EUR | 8.5 million EUR |
| 2020 | -33.6 million EUR | 5.3 million EUR |
| 2019 | -30.2 million EUR | 11.3 million EUR |
| 2018 | -33.6 million EUR | 3.2 million EUR |
| 2017 | -19.1 million EUR | 4.8 million EUR |
| 2016 | -7.0 million EUR | 9.4 million EUR |
0RNK.L
Price: €3.20
52 week price:
Earnings Per Share: -1.27 EUR
P/E Ratio: -2.34
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Market Capitalization: 570342